Trials / Unknown
UnknownNCT02414308
Management of Peyronie's Disease With Adipose Tissue Stem Cell
The Role of Adipose Tissue Stem Cell Injection Through Corpora Cavernosa and Intra Dorsal Penile Artery in Management of Erectile Dysfunction Associated With Peyronie's Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Man Clinic for Andrology, Male Infertility and Sexual Dysfunction · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Accepted
Summary
Erectile dysfunction is growing in prevalence all over the world and one of the most existing disease in old age patients There is many lines of treatment concerning the status of patient like psychosexual, medical, and surgical treatment But Pyronie's disease is common now among people especially diabetics, and the role of treatment still controversial in results We can start conservative treatment and then surgical treatment if fail but the outcome still not convinced Many patients refuse to fix penile prosthesis and to make operation like nesbite for probability of shortening of penis We start to use stem cell in patients have erectile dysfunction and Peyronie's disease The injection of stem cell will be at corpora cavernosa and intra dorsal penile artery under Doppler device guidance
Detailed description
Peyronie's disease associated with erectile dysfunction nan be treated by different methods We start to treat such patients with adipose tissue stem cell Harvesting stem cell from adipose tissue and injected into corpora cavernosa and penile artery and we assess quality of erection through patient history and penile duplex and also assess plaque size and other symptoms related to Peyronie's disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adipose tissue stem cell injection | Stem cell will be harvested through adipose tissue by liposuction and isolation occurred Injection will distribute through corpora cavernosa and dorsal penile artery |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2016-05-01
- Completion
- 2016-07-01
- First posted
- 2015-04-10
- Last updated
- 2015-04-10
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02414308. Inclusion in this directory is not an endorsement.